Outcomes and Prognostic Factors of Octogenarians With Primary CNS Lymphoma Treated With High-Dose Methotrexate
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia and Lymphoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Outcome and prognostic factors of very old patients with primary CNS lymphoma: a retrospective analysis of patients ≥80 years treated with high-dose methotrexate-based chemotherapy
Leukemia and Lymphoma 2022 Jul 20;[EPub Ahead of Print], S Seidel, T Kowalski, V Nilius-Eliliwi, R Schroers, U SchlegelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.